livemint.com
68%
193
UK strikes pact for 60 million doses of COVID-19 experimental vaccine
LONDON : The UK government on Wednesday announced an early access agreement with GlaxoSmithKline (GSK) and Sanofi Pasteur for an estimated 60 million doses of an experimental new vaccine being tested to combat COVID-19.The agreement with Britain's GSK and France's Sanofi, which combined have among the largest vaccine manufacturing capabilities in the world, will supply the UK with 60 million doses of their vaccine based on existing DNA-based technology used to produce Sanofi’s flu vaccine.While it remains uncertain as to which, if any, of the anti-coronavirus vaccines under various stages of development around the world will ultimately work, the British government said the latest deal helps grow the country’s portfolio of vaccine candidates